Neogen Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Neogen Corporation's yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $29 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 93% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 23% of its market value (net debt). Lower than 86% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (May 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
0.7×Over the last 3 years its own operating cash paid for 66% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Higher than 66% of Healthcare companies in United States.
Cash Locked Ratio
$24For every $100 of sales, $24 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $25 tied up three years earlier.
Less money tied up than 51% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Less steady than 51% of Healthcare companies in United States.
Growth Efficiency Ratio
$31Sales grew 6% in 3 years; of every extra $100 of sales, $31 became extra profit.
Higher than 58% of Healthcare companies in United States.
Asset Productivity Ratio
+6% / -27%In 3 years sales changed by +6% while total assets changed by -27%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
−23%Debt, after subtracting cash, equals 23% of its market value (net debt).
Lower than 86% of Healthcare companies in United States.
Tangible Assets Ratio
29%Of every $100 the company owns, $29 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 93% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 77% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Neogen Corporation made a loss over the last year. Neogen Corporation owes $0.37 for every $1 it owns. Neogen Corporation made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results May 2026.
P/E ratio
LossNeogen Corporation made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.25The share price is 1.25 times Neogen Corporation's book value per share, lower than 74% of Healthcare companies in United States.
Market cap
$2.6 BThe total market value of all of Neogen Corporation's shares at today's price (share price × number of shares), larger than 79% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$2.1 BWhat Neogen Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 May 2026).
Book value per share
$9.59Net worth divided by the number of shares. The share price of $11.98 is 1.2 times this, which is the P/B above.
Return on equity (ROE)
-2.7%Neogen Corporation lost 2.7% of its shareholders' money over the last year, higher than 74% of Healthcare companies in United States.
Owes vs Owns
0.37×Neogen Corporation owes $0.37 for every $1 it owns (low), lower than 54% of Healthcare companies in United States.
Dividend yield
NoneNeogen Corporation does not currently pay a dividend.
Revenue growth
-3%Revenue fell 3% in the year to May 2026, and grew 2% a year on average over 3 years.
Profit growth
LossNeogen Corporation made a loss in each of the last two years.
Profit margin
-0.9%Neogen Corporation lost $1 for every $100 of revenue.
Interest cover
Not coveredNeogen Corporation's operating profit did not cover its interest costs in the year to May 2026.
Cash vs debt
Net debtNeogen Corporation had $608 M more debt than cash (net debt) at May 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Neogen Corporation: $2.6 B ÷ $2.1 B (31 May 2026) = 1.2.
What is Neogen Corporation's return on equity?
Neogen Corporation lost 2.7% of its shareholders' money over the last year, higher than 74% of Healthcare companies in United States.
How much does Neogen Corporation owe compared with what it owns?
Neogen Corporation owes $0.37 for every $1 it owns (low), lower than 54% of Healthcare companies in United States.
Does Neogen Corporation pay a dividend?
No. Neogen Corporation does not currently pay a dividend.
Is Neogen Corporation's revenue growing?
Revenue fell 3% in the year to May 2026, and grew 2% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.